KEYS vs ZYME · P/E 57, rev $4.98B vs rev $76.3M
Keysight Technologies Inc (KEYS) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
KEYS currently screens at market cap $59.84B and trailing P/E 56.5. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the KEYS and ZYME stock pages for the full models.
Not investment advice.